Edgewise Therapeutics share price logo

Edgewise Therapeutics

NASDAQ: EWTX

Mid Cap

$40.04

-0.26

(-0.65%)

as on

Edgewise Therapeutics Stock Performance

as on October 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $39.34
    $41.03
    downward going graph

    1.75%

    Downside

    2.47%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $14.25
    $48.51
    downward going graph

    64.41%

    Downside

    21.15%

    Upside

    downward going graph

Edgewise Therapeutics share price movements today

Previous Close
$40.30
Open
$40.49
Volume
916.4K
Market Cap
$4.5B
Day's Low - High
$39.34 - $41.03
52 Week Low - High
$14.25 - $48.51

Edgewise Therapeutics Historical Returns

1 Month Return
-6.43 %
3 Month Return
+ 0.5 %
1 Year Return
+ 162.54 %
3 Year Return
+ 469.21 %
5 Year Return
+ 122.41 %

Edgewise Therapeutics Stock Fundamentals & Key Indicators

Check Edgewise Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.5B

EPS (TTM)

-1.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-22.38

Industry PE ratio

-11.69

PEG Ratio

1.28

EBITDA

-197.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-39.01%

Edgewise Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Edgewise Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$4.5B122.41%-22.380.00%0.00%
StrongBuy$44.3B650.56%-23.320.00%0.00%
Neutral$75.9B-32.81%-23.81-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B32.91%17.5584.86%0.50%

Stock Returns calculator for Edgewise Therapeutics Stock including INR - Dollar returns

The Edgewise Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Edgewise Therapeutics investment value today

Current value as on today

₹2,83,483

Returns

₹1,83,483

(+183.48%)

Returns from Edgewise Therapeutics Stock

₹1,60,847 (+160.85%)

Dollar Impact

₹22,636 (+22.64%)

Analyst Recommendation on Edgewise Therapeutics Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Edgewise Therapeutics. Average target price of $52.62

Edgewise Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Edgewise Therapeutics.

What analysts predicted

23.91%UPSIDE

Target Price

$52.62

Current Price

$40.04

Analyzed by

8 Analysts

High

$60

Target

$52.62

Low

$36

Edgewise Therapeutics target price $52.62, a slight upside of 23.91% compared to current price of $40.04. According to 8 analysts rating.

Indian Investors' Interest in Edgewise Therapeutics Stock

Search interest for Edgewise Therapeutics Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

Edgewise Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
-
Operating Income
-34
-38
-40
-45
-45
-42
-46
-55
-54
-61
EBITDA
-28
-30
-33
-39
-40
-35
-40
-51
-48
-56
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
-1
0
0
Income Before Tax
-28
-31
-34
-39
-40
-36
-40
-50
-49
-57
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-28
-31
-34
-39
-40
-36
-40
-50
-49
-57
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Edgewise Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-2
Operating Income
-9
-17
-43
-71
-114
-158
-191
EBITDA
-9
-17
-42
-63
-98
-131
-165
Interest Expense
-
-
-
4
-
-
-
Depreciation
0
0
0
0
1
2
2
Income Before Tax
-9
-17
-42
-67
-100
-133
-167
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-9
-17
-42
-67
-100
-133
-167
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Edgewise Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-28
-31
-34
-39
-40
-36
-40
117
-49
-57
Operating Cash Flow
-28
-26
-27
-26
-37
-32
-34
-38
-42
-43
Investing Cash Flow
-268
37
25
20
43
-162
35
49
2
78
Financing Cash Flow
241
1
3
2
2
188
1
3
12
-9
Change in Cash
-55
13
1
-3
8
-6
2
15
-27
25

Edgewise Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-17
-42
-67
-100
-133
-167
Operating Cash Flow
-9
-14
-33
-52
-91
-109
-143
Investing Cash Flow
0
-24
-242
-70
102
-184
-32
Financing Cash Flow
24
120
186
129
53
249
196
Change in Cash
15
81
-89
6
64
-44
19

Global Institutional Holdings in Edgewise Therapeutics

Check out the Institutions with significant holdings in Edgewise Therapeutics.

Funds
Holdings
Peter Kolchinsky
7.73%
Richard Driehaus
4.35%
Vanguard
4.14%
Joseph Edelman
4.03%
iShares
3.60%

Insights on Edgewise Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, EWTX stock has moved up by 162.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EWTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 637.9% return, outperforming this stock by 475.4%

About Edgewise Therapeutics

Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
OrganisationEdgewise Therapeutics
Headquarters1715 38th Street, Boulder, CO, 80301, US
IndustryBiotechnology
CEOKevin Koch

Key Management of Edgewise Therapeutics

Name

Title

Dr. Badreddin Edris Ph.D.

Co-Founder & Independent Director

Mr. Michael P. Nofi

Chief Financial Officer

Mr. John R. Moore J.D.

General Counsel

Dr. Aylin Tugcu

Senior Vice President of Cardiovascular Clinical Development & Medical Affairs

Dr. Joanne M. Donovan M.D., Ph.D.

Chief Medical Officer

Dr. Peter A. Thompson FACP, M.D.

Co-Founder & Independent Chairman

Dr. Kevin Koch Ph.D.

President, CEO & Director

Dr. Alan J. Russell Ph.D.

Co-Founder, Chief Scientific Officer & Director

Dr. Behrad Derakhshan Ph.D.

Chief Operating Officer

FAQs

What is Edgewise Therapeutics share price today?

Edgewise Therapeutics share price today is $40.04 as on at the close of the market. Edgewise Therapeutics share today touched a day high of $41.03 and a low of $39.34.

What is the 52 week high and 52 week low for Edgewise Therapeutics share?

Edgewise Therapeutics share touched a 52 week high of $48.51 on and a 52 week low of $14.25 on . Edgewise Therapeutics stock price today i.e. is closed at $40.04,which is 17.46% down from its 52 week high and 180.98% up from its 52 week low.

What is Edgewise Therapeutics's market capitalisation today?

Edgewise Therapeutics market capitalisation is $0.00T as on .

How to invest in Edgewise Therapeutics Stock (EWTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Edgewise Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Edgewise Therapeutics Stock (EWTX) from India?

Indian investors can start investing in Edgewise Therapeutics (EWTX) shares with as little as ₹96.419998168945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹964.20 in Edgewise Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Edgewise Therapeutics share’s latest price of $40.04 as on October 7, 2026 at 1:29 am IST, you will get 0.2498 shares of Edgewise Therapeutics. Learn more about fractional shares .

What are the returns that Edgewise Therapeutics has given to Indian investors in the last 5 years?

Edgewise Therapeutics stock has given 122.41% share price returns and 28.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?